Insights

Innovative Cancer Therapeutics NanoValent Pharmaceuticals specializes in targeted nanosphere technology for cancer treatment, presenting a cutting-edge solution that could appeal to research institutions, biotech firms, and hospitals seeking novel oncology therapies.

Strategic Partnerships The collaboration with Children's Hospital Los Angeles indicates an openness to partnerships for advanced research and clinical development, creating opportunities for joint ventures, licensing, or co-development of new nano-based therapeutics.

Patent Portfolio Strength Securing a significant US patent for targeted polymerized nanoparticles solidifies NanoValent’s intellectual property position, making it attractive for licensing deals or potential acquirers looking to enhance their oncology pipelines.

Growth Potential With current revenues between 1M and 10M and ongoing innovation, NanoValent offers growth prospects for investors or partners interested in early-stage biotech companies with impactful technology and market differentiation.

Emerging Market Focus Operating in the competitive biotech landscape with peers like Selecta Biosciences and Cerulean Pharma, NanoValent presents opportunities for market entry strategies targeting tumor-targeted nanotherapies and personalized medicine sectors.

NanoValent Pharmaceuticals, Inc. Tech Stack

NanoValent Pharmaceuticals, Inc. uses 8 technology products and services including oEmbed, Font Awesome, Twemoji, and more. Explore NanoValent Pharmaceuticals, Inc.'s tech stack below.

  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • Twemoji
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Nginx
    Web Servers
  • prettyPhoto
    Web Tools And Plugins

NanoValent Pharmaceuticals, Inc.'s Email Address Formats

NanoValent Pharmaceuticals, Inc. uses at least 1 format(s):
NanoValent Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@nanovalent.comJDoe@nanovalent.com
39%
Last@nanovalent.comDoe@nanovalent.com
11%
FLast@nanovalent.comJDoe@nanovalent.com
39%
Last@nanovalent.comDoe@nanovalent.com
11%

Frequently Asked Questions

Where is NanoValent Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc.'s main headquarters is located at 351 b Evergreen Drive Bozeman, Montana 59715 United States. The company has employees across 2 continents, including North AmericaEurope.

What is NanoValent Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc.'s official website is nanovalent.com and has social profiles on LinkedInCrunchbase.

What is NanoValent Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NanoValent Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, NanoValent Pharmaceuticals, Inc. has approximately 4 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: M. L.COO: M. L.Co-Founder And Chief Scientific Officer: J. N.. Explore NanoValent Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does NanoValent Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc. operates in the Biotechnology Research industry.

What technology does NanoValent Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc.'s tech stack includes oEmbedFont AwesomeTwemojiGoogle CloudjQueryWP EngineNginxprettyPhoto.

What is NanoValent Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@nanovalent.com. Find more NanoValent Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has NanoValent Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, NanoValent Pharmaceuticals, Inc. has raised $510K in funding. The last funding round occurred on Sep 16, 2013 for $510K.

When was NanoValent Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
NanoValent Pharmaceuticals, Inc. was founded in 2006.

NanoValent Pharmaceuticals, Inc.

Biotechnology ResearchMontana, United States2-10 Employees

NanoValent Pharmaceuticals, Inc. is a pharmaceutical company developing a new nano-particle based TNS (Targeted NanoSpheres) technology to create and develop novel cancer therapies

Section iconCompany Overview

Headquarters
351 b Evergreen Drive Bozeman, Montana 59715 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2006
Employees
2-10

Section iconFunding & Financials

  • $510K

    NanoValent Pharmaceuticals, Inc. has raised a total of $510K of funding over 1 rounds. Their latest funding round was raised on Sep 16, 2013 in the amount of $510K.

  • $1M$10M

    NanoValent Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $510K

    NanoValent Pharmaceuticals, Inc. has raised a total of $510K of funding over 1 rounds. Their latest funding round was raised on Sep 16, 2013 in the amount of $510K.

  • $1M$10M

    NanoValent Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.